Repurposing DPP-4 Inhibitors for Colorectal Cancer: A Retrospective and Single Center Study

SIMPLE SUMMARY: Colorectal cancer is one of the most common causes and the leading cause of cancer deaths worldwide. Its poor prognosis highlights the urgent need for more effective treatments. Repurposing approved drugs is a promising strategy as preclinical screenings can be minimized. The aim of...

Descripción completa

Detalles Bibliográficos
Autores principales: Ng, Lui, Foo, Dominic Chi-Chung, Wong, Carlos King-Ho, Man, Abraham Tak-Ka, Lo, Oswens Siu-Hung, Law, Wai-Lun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306906/
https://www.ncbi.nlm.nih.gov/pubmed/34298800
http://dx.doi.org/10.3390/cancers13143588

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306906/
https://www.ncbi.nlm.nih.gov/pubmed/34298800
http://dx.doi.org/10.3390/cancers13143588

Ejemplares similares